Prof. Martin Savage, Professor Emeritus in Paediatric Endocrinology at the William Harvey Research Institute, Barts and the London School of Medicine and Dentistry in London, UK, provides his expert insight into key data presented at ESPE 2018 and what they may mean for optimizing clinical outcomes for patients with severe primary IGF-1 disorder (SPIGFD).
Prof. Stefano Cianfarani, Associate Professor of Paediatrics and Chief of the Molecular Endocrinology Unit, ‘Bambino Gesù’ Children’s Hospital, Rome, Italy, provides his expert insight into key data presented at ESPE 2018 and what they may mean for optimizing clinical outcomes for patients with severe primary IGF-1 disorder (SPIGFD).
Please Select A Video:
Learning Objectives & Overview
Watch a series of internationally renowned clinical specialists discuss the clinical landscape for severe primary IGF-1 deficiency (SPIGFD), including data from the European Society for Paediatric Endocrinology (ESPE) 2018 Congress in Athens, Greece, 27–29 September 2018.
The potential implications of these data for optimizing clinical outcomes for patients with SPIGFD are explored from both global and regional perspectives.
The information in this activity is intended for European endocrinologists, nurses, and other healthcare professionals involved in the treatment of patients with short stature.
After watching these touchCONGRESS Expert Interviews, you should be better prepared to:
- Share your increased awareness and understanding of SPIGFD
- Contribute to the optimization of diagnosis in paediatric growth hormone insensitivity syndromes
- Demonstrate increased familiarity and confidence with early treatment of SPIGFD
- Drive improved patient outcomes through sharing of best practice.